Connect with us

St. Jude Medical to pay $27 mln to settle allegations over heart devices

HBS Reporting

St. Jude Medical to pay $27 mln to settle allegations over heart devices

St. Jude Medical to pay $27 mln to settle allegations over heart devices

WASHINGTON, July 8 (Reuters) – St. Jude Medical, which was acquired by Abbott Laboratories (ABT.N) in 2017, has agreed to pay $27 million to settle allegations it knowingly sold defective heart devices, the U.S. Justice Department said on Thursday.

It said St. Jude allegedly failed to disclose serious adverse health events in connection with premature battery depletion in certain models of its implantable defibrillators that were sold between November 2014 and October 2016.

“This relates to a matter that took place prior to Abbott’s acquisition of St. Jude Medical,” Abbott said in a statement.

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in HBS Reporting